UK: +44 1379 658 721
Ireland: +353 89 221 3723
USA: +1 754 252 3536
Middle East - N. Africa: + 971 52 873 4738
Australia: +61 3 9310 5259
One of the best ways to get an accurate picture of the pandemic’s ongoing progress is to take a look at what’s happening around the world. Here’s the latest covid news, in a week where UK covid cases shot up by 13.5% compared to the week before, with another 32, 253 new infections.
New Zealand’s no tolerance covid policy is under threat
New Zealand is struggling to cope with an outbreak of delta so serious it might bring an end to the country’s impressive no tolerance policy. Prime Minister Jacinda Ardern said there have already been over 320 ‘locations of interest’ linked to the outbreak and 13,000 contacts recorded. In her words, “Delta has changed the rules of the game."
In Australia, Sydney is suffering. The city’s lockdown has been extended until the end of September and there’s a curfew on the cards every night from 23rd August onwards for 2 million people living in the 12 worst-affected areas.
The UK government’s approved covid testing provider list has been slashed
57 companies are due to be taken off the UK government's list of approved covid testing providers after a quality and pricing review returned shockingly bad results. The review looked at companies offering day two and day eight tests for overseas arrivals. Many of the companies didn’t have the right accreditation and others were charging far too much.
Young people with long covid make a vaccine appeal to their age group
The NHS has released a new video starring young people who are suffering with long covid, appealing for others in the age group to get their jabs. All three are in their early 20s and 30s and were perfectly healthy before catching the virus. One ended up being hospitalised and was sure he was going to die. People aged 16 - 29 are the most at risk of long covid, but at the same time vaccine take-up has been lower than average in the group.
Ronapreve given the OK to treat covid symptoms in the UK
The UK has approved using a drug called Ronapreve to treat covid. It uses artificial antibodies to prevent as well as fight the illness. It’s apparently useful for preventing infection, treating acute symptoms, and cutting the risk of being admitted to hospital. Ronapreve has been developed by the pharmaceutical giants Regeneron and Roche and can be taken either as an infusion or a jab. It sticks to the virus inside the respiratory system, stopping it from actually getting inside cells. At the same time, a new antibody drug from AstraZeneca reduces the chance of getting symptomatic covid by 77%.
The UK’s booster campaign – The latest
The UK government is ‘confident’ that their planned booster jab campaign can start in September. But at the same time they’re waiting for the Joint Committee on Vaccination and Immunisation’s final advice before pressing the button. Adam Finn, a Committee member, told the BBC he thinks there is enough evidence for boosters but at the same time said, “I think we do need more evidence before we can make a firm decision on a much broader booster programme.” He added that it was “less clear really whether a third dose in a more general way, for sort of all people above a certain age, is really going to make very much difference.”
Waning vaccine effectiveness and the delta variant
A piece of research carried out in the UK reveals how protection from the Pfizer/BioNTech and Oxford/AstraZeneca vaccines reduces as time passes. While they both give great protection against symptomatic infection by delta, they’re about 15% less effective against delta than they are against alpha. There are also hints that vaccinated people who catch delta could be just as infectious as people who haven’t been vaccinated at all, and that’s very worrying.
What does the latest covid news tell us?
Roll all this news together and what do you get? We’re reminded that delta is a serious adversary, able to flout the best-laid plans of countries whose zero tolerance covid policy was highly effective against the early variants. We understand there are still questions around the efficacy or otherwise of a third top-up jab. And while pharmaceutical companies are pulling out all the stops to create new ways to treat the virus, the pandemic still has a very long way to go.
All this means it makes a lot of sense to get your business prepared for the long haul, with proven UVC light technology that uses environmentally friendly LED lights to mess with the virus’ RNA and DNA so badly it can’t reproduce, so it dies. It works, it’s been used in healthcare settings for decades, and our machines help keep your staff, suppliers and customers safe. It’s fast, effective, and great value for money. Let’s explore the potential!